[Federal Register Volume 62, Number 149 (Monday, August 4, 1997)]
[Notices]
[Page 41976]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-20406]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--APEX Medical Inc. and the East Development 
Group, Inc.

    Notice is hereby given that, on July 11, 1997, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. Sec. 4301 et seq. (``the Act''), APEX Medical, Inc., and the 
East Development Group, Inc. have filed written notifications 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing (1) the identities of the parties and (2) the 
nature and objective of the venture. The notifications were filed for 
the purpose of extending the Act's provisions limiting the recovery of 
antitrust plaintiffs to actual damages under specified circumstances. 
Pursuant to Section 6(b) of the Act, the identities of the parties are 
APEX Medical, Inc., East Walpole, MA and the East Development Group, 
Inc., East Walpole, MA. The general area of planned activity is to 
design a miniature totally implantable blood pressure sensing and 
monitoring system for long term human implantation. Such a device would 
monitor blood pressure in conjunction with artificial hearts or drug 
infusion devices.
Constance K. Robinson,
Director of Operations, Antitrust Division.
[FR Doc. 97-20406 Filed 8-1-97; 8:45 am]
BILLING CODE 4410-11-M